Defiance

Could Biotech ETFs Be Due For More Upside?

Could Biotech ETFs Be Due For More Upside?

By Ian YoungOctober 8, 2021

Biotech ETFs Benefit From Moderna Dual Booster Shot News

Biotech ETFs Benefit From Moderna Dual Booster Shot News

By Ian YoungSeptember 9, 2021

Could Biotech ETFs Get Another Boost From JNJ News?

Could Biotech ETFs Get Another Boost From JNJ News?

By Ian YoungAugust 26, 2021

Biotech ETFs Already Benefitting From Pfizer Vaccine Full-Approval

Biotech ETFs Are Already Benefitting from Pfizer Vaccine’s Full Approval

By Ian YoungAugust 23, 2021

Nasdaq Portfolio Solutions Channel

Bet on Biotech Small Caps to Bounce Back

Bet on Biotech Small Caps to Bounce Back

By Tom LydonAugust 19, 2021

Smart Beta Channel

A Mind-Blowing Psychedelics ETF Hits the Market

A Mind-Blowing Psychedelics ETF Hits the Market

By Ben HernandezJune 2, 2021

Multi-Asset Channel

The Blank-Check Boom: 'SPAK' Hits $100 Million in AUM

The Blank-Check Boom: ‘SPAK’ Hits $100 Million in AUM

By Tom LydonFebruary 16, 2021

Innovative ETFs Channel

Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021

Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021

By Max ChenDecember 31, 2020

Nasdaq Portfolio Solutions Channel

Young But Hungry: A New Defiance ETF is Defying Expectations

By Tom LydonNovember 13, 2020

Disruptive Technology Channel

Could Apple's New iPhone Help Boost 5G ETFs?

Could Apple’s New iPhone Help Boost 5G ETFs?

By Ian YoungOctober 12, 2020